<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>9972593</identifier>
<setSpec>0300-5062</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Salmerón, J M</dc:author>
<dc:author>Alcántara, A G</dc:author>
<dc:author>Barcia, D</dc:author>
<dc:description xml:lang="en">We present the use of risperidone as a potentiation strategy of the serotonergic antidepressants in four patients suffering from refractory obsessive-compulsive disorder. There were an important improvement in three patients. Adding risperidone to serotonergic antidepressants causes complex interactions between serotonergic, dopaminergic and noradrenergic systems, that could lay to the clinical improvement. These and other similar cases make necessary controlled studies. Adding risperidone to serotonergic antidepressants in patients suffering from refractory obsessive-compulsive disorder might be an effective strategy with low risk for secondary effects and without the presence of tics or psychotic symptoms.</dc:description>
<dc:type>Clinical Trial</dc:type>
<dc:language>es</dc:language>
<dc:date>1998 Nov-Dec </dc:date>
<dc:title xml:lang="es">Combinación de risperidona y antidepresivos serotoninérgicos en el trastorno obsesivo compulsivo refractario.</dc:title>
<dc:title xml:lang="en">[Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].</dc:title>
<dc:publisher>Actas luso-espanolas de neurologia, psiquiatria y ciencias afines</dc:publisher>
</metadata>
</record>
</pubmed-document>
